Skip to main content

What Zimmer Biomet's Quarter ended Sep 30, 2026 10-Q says: 6 signals

Zimmer Biomet filed its latest 10-Q with the SEC on Nov 4, 2026. It discusses capex increase, channel shift and cost reduction.

Public (ZBH)Medical Equipment Manufacturing10,000+ employeeszimmerbiomet.comLinkedIn

Get Zimmer Biomet's live signals in Claude or ChatGPT, or by API

AskWhat changed at Zimmer Biomet this week? Use Autobound signals for zimmerbiomet.com.
Filed
Nov 4, 2026
Period
Quarter ended Sep 30, 2026
Filings
3
Signals
16

Source: Autobound Signal API · 80 signals tracked for Zimmer Biomet · updated

10-Q · latest 10

What Zimmer Biomet's 10-Q filings say

  1. 10-Q · Quarter ended Sep 30, 2026

    Filed · 6 signals

    SEC EDGAR
  2. 10-Q · Quarter ended Jun 30, 2026

    Filed · 6 signals

    SEC EDGAR

Earlier 10-Q filings

  • 10-Q · Quarter ended Mar 31, 2026Filed · 4 signalsSEC EDGAR

Showing 10 of 16 filing signals. The Signal API returns all of them.

Get them with one API call

Earnings calls

Zimmer Biomet earnings headlines

From earnings call transcripts (Signal API type earnings-transcripts).

Earnings call headlines
Call dateWhat the company said
Over 75% of U.S. sales force converted to dedicated modelThe company is 3 quarters into an 8-quarter initiative named Project Optima to transition to a specialized direct sales force. While generating short-term disruption in knees, rep turnover remains in the single digits as dedicated specialists are added across high-growth franchises.
Expanded exclusive distribution and supply agreement with THINK SurgicalThe company entered into an extended multiyear distribution and supply agreement with THINK Surgical for an exclusive version of the wireless handheld TMINI robotic system compatible with Persona Knee. The platform targets outpatient settings and ambulatory surgery centers.
Knee business declines 2.6% amid commercial disruption and market headwindsKnee segment sales contracted 2.6% on a constant currency basis, driven by a 2% decline in the U.S. and 3.4% internationally. Management attributed the U.S. drop to a sales force transition and stiff competition, alongside ongoing China distributor headwinds.
Consolidating manufacturing footprint into Warsaw and lower-cost international sitesZimmer Biomet is closing select underutilized manufacturing plants and shifting domestic operations into multiple facilities in Warsaw, Indiana. Simultaneously, international manufacturing is shifting to lower-cost regions to address a 46% OpEx-to-sales ratio.
Targeting 46% OpEx reduction via AI automation and India centerLeadership is seeking operating expense efficiency to reduce the 46% OpEx-to-sales ratio, targeting the $2.8 billion non-variable portion. Initiatives include partnering with AI implementation experts for transactional reengineering and scaling a global capability center in India.
Adjusted gross margin down 90 bps to 71.7% on manufacturing costsGross margin declined by 90 basis points year-over-year to 71.7%, primarily impacted by higher manufacturing costs and 70 basis points of pricing erosion, partially offset by favorable product mix.

Signal API · MCP

Track Zimmer Biomet with the Signal API

One POST /v1/companies/enrich call with zimmerbiomet.com returns Zimmer Biomet 10-Q signals (sec-10q), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"zimmerbiomet.com","signal_types":["sec-10q"],"limit":20}'

Bulk data

Need this signal for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real 10-Q Filings records, as a CSV.

Talk to sales

Same industry

Questions about Zimmer Biomet 10-Q

When did Zimmer Biomet file its latest 10-Q?
Zimmer Biomet filed its latest 10-Q (Quarter ended Sep 30, 2026) on Nov 4, 2026. The one before it was filed on Aug 5, 2026.
What did Zimmer Biomet disclose in its latest 10-Q?
From the filing dated Nov 4, 2026: Restructuring plans incur $146 million and $37 million toward targeted exit costs
What did Zimmer Biomet say on its recent earnings calls?
Q3 FY2026: Over 75% of U.S. sales force converted to dedicated model (dated Nov 4, 2026).
Where can I read Zimmer Biomet's 10-Q filing?
The full filing is on SEC EDGAR: https://www.sec.gov/Archives/edgar/data/1136869/000119312526447203/zbh-20260930.htm. This page summarizes what the filing says and links to it.

Page updated , the date of the newest row on this page.

Source. Quarterly reports (Form 10-Q) filed with the SEC. Every card links to the filing on EDGAR.

Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.

Data as of .

How this data is built →Get it from the Signal API →